Thursday, January 7, 2021

Watch Highlighted Content Sessions On-Demand

By accessing Virtual Expo Connect free of charge
Watch all Online Content On-Demand
of CPhI & P-MEC China Virtual Expo Connect  
CPhI & P-MEC China Virtual Expo Connect 2020 has finished successfully. The various virtual content features are now available to be watched on-demand on the platform. The matchmaking system China Pharma Connect is still live for you to connect with suppliers till 31st January.
 
If you have missed the event, the good news is that it’s never too late to register to unlock all features of Virtual Expo Connect. It’s completely free of charge!
Virtual tours of the live exhibition are available through the VR show.
Tours will give virtual attendees a bird’s eye view of the entire 200,000 m2 exhibition venue with a zoom on hundreds of exhibitor booths.
Highlighted On-Demand Sessions
Guided Tours
Exploring High-quality Pharma API Suppliers
 
Discover High-Tech Drug Delivery Devices
CRO & CMO Services Suppliers in China
 
Natural Extracts Quality Products Innovation Tour
Sneak Peek at Latest Chromatographic Instrument and System
Discover Innovation in the Pharma Excipients Industry
Conference Webcasts
  • Early Stage Considerations for the Manufacture and Delivery of Vaccines
  • China: What does the Future of API Production Look Like?
  • Market Outlook: China
  • Pharma Outlook 2021
Exhibitors’ Talk
Porton Pharma
Ji Yaohui
Vice President of R&D
North China 
Wang Jun
President
Zhejiang Canaan
Cherry Chen
Director of Int’l Business Dept.
Tofflon
Michael Chang
Senior Vice President
Merck
Florian Wohlfart
Senior Director & Head of Commercial APAC 
 
Gan & Lee
Jason Wu
Director of International Business Affairs
Zhejiang Langhua
Cynthia Ban
CEO, Langhua
General Manager, Nuobai
Corning Pharmaceutical
Chunmei Lin
General Manager
What else is in for you?
More opportunities for connection and sourcing
Digital Showroom
Online Matchmaking
[AD] Feellife Health Inc.
 
CPhI & P-MEC China Virtual Expo Connect
https://vec.pharmasources.com

No comments:

Post a Comment